ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 198 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $350,939 | +24.2% | 16,300 | -1.2% | 0.00% | 0.0% |
Q1 2024 | $282,474 | -42.2% | 16,490 | +1.2% | 0.00% | 0.0% |
Q4 2023 | $488,511 | +48.2% | 16,300 | +1.3% | 0.00% | 0.0% |
Q3 2023 | $329,684 | +4.2% | 16,090 | +1.0% | 0.00% | 0.0% |
Q2 2023 | $316,529 | +12.1% | 15,930 | -3.4% | 0.00% | 0.0% |
Q1 2023 | $282,474 | -12.5% | 16,490 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $322,709 | +12.8% | 16,490 | -7.9% | 0.00% | 0.0% |
Q3 2022 | $286,000 | +16.3% | 17,900 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $246,000 | -11.2% | 17,900 | +2.3% | 0.00% | 0.0% |
Q1 2022 | $277,000 | -27.5% | 17,490 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $382,000 | -26.4% | 17,490 | +0.7% | 0.00% | 0.0% |
Q3 2021 | $519,000 | -32.5% | 17,364 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $769,000 | +15.5% | 17,364 | +15.6% | 0.00% | 0.0% |
Q1 2021 | $666,000 | -19.6% | 15,016 | -0.6% | 0.00% | -50.0% |
Q4 2020 | $828,000 | +137.2% | 15,106 | -1.0% | 0.00% | +100.0% |
Q3 2020 | $349,000 | +14.1% | 15,266 | +4.4% | 0.00% | 0.0% |
Q2 2020 | $306,000 | – | 14,626 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |